ROTHSCHILD & CO ASSET MANAGEMENT US INC. – Neurocrine Biosciences, Inc. Transaction History
ROTHSCHILD & CO ASSET MANAGEMENT US INC. portfolio value:
$6.84M
portfolio value
ROTHSCHILD & CO ASSET MANAGEMENT US INC. quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -12.91% | -9.54K shares | -368K | $106.21 | 64.41K |
| Q2 2022 | share | Decrease | -5.79% | -4.54K shares | -151K | $97.48 | 73.96K |
| Q1 2022 | share | Decrease | -22.47% | -22.75K shares | -1.26M | $93.75 | 78.51K |
| Q4 2021 | share | Increase | +14.08% | 12.49K shares | 111K | $84.63 | 101.26K |
| Q3 2021 | share | Decrease | -7.24% | -6.93K shares | -800K | $95.91 | 88.77K |
| Q2 2021 | share | Decrease | -10.17% | -10.83K shares | -1.04M | $97.32 | 95.70K |
| Q1 2021 | share | Decrease | -31.13% | -48.15K shares | -4.46M | $97.25 | 106.53K |
| Q4 2020 | share | Increase | +14.55% | 19.64K shares | 1.84M | $95.85 | 154.69K |
| Q3 2020 | share | Decrease | -17.78% | -29.20K shares | -7.05M | $96.16 | 135.04K |
| Q2 2020 | share | Decrease | -21.57% | -45.17K shares | 1.91M | $122 | 164.25K |
| Q1 2020 | share | Decrease | -8.08% | -18.39K shares | -6.36M | $86.55 | 209.42K |
| Q4 2019 | share | Decrease | -4.42% | -10.54K shares | 3.00M | $107.49 | 227.82K |
| Q3 2019 | share | Increase | +13.46% | 28.27K shares | 3.74M | $90.11 | 238.36K |
| Q2 2019 | share | Increase | +39.99% | 60.01K shares | 4.51M | $84.43 | 210.08K |
| Q1 2019 | share | Increase | +63.76% | 58.42K shares | 6.67M | $88.1 | 150.07K |
| Q4 2018 | share | Increase | +37.26% | 24.87K shares | -1.66M | $71.41 | 91.64K |
| Q3 2018 | share | Increase | 0.00% | 66.76K shares | 8.20M | $122.95 | 66.76K |
| Q1 2018 | share | Decrease | -100.00% | -26.52K shares | -2.05M | $82.93 | 0 |
| Q4 2017 | share | Decrease | -29.73% | -11.22K shares | -255K | $77.59 | 26.52K |
| Q3 2017 | share | Decrease | -0.30% | -114 shares | 571K | $61.28 | 37.74K |
| Q2 2017 | share | Decrease | -5.99% | -2.41K shares | -2K | $46 | 37.85K |
| Q1 2017 | share | Decrease | -4.45% | -1.87K shares | 113K | $43.3 | 40.27K |
| Q4 2016 | share | Increase | +442.10% | 34.37K shares | 1.23M | $38.7 | 42.14K |
| Q3 2016 | share | Increase | +0.06% | 5 shares | 41K | $50.64 | 7.77K |
| Q2 2016 | share | Increase | 0.00% | 7.77K shares | 353K | $45.45 | 7.77K |